BRTX - biorestorative.com Debt to Book Capitalization Ratio

Brandmark of biorestorative.com (BRTX)

BioRestorative Therapies (BRTX) is recognized as an innovator in spinal regeneration, developing non-surgical treatment methods. The debt-to-book capitalization trend clearly illustrates financial stability, where the value of 0.01 determines this level. The business relies on external financing due to regulatory risks, while the binary threats of a single-product pipeline are mitigated by the development of metabolic obesity therapy.

BRTX (BioRestorative Therapies, Inc.) Debt to Book Value history from 07/04/2022 to 10/28/2026

biorestorative.com (BRTX) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price BioRestorative Therapies, Inc.|BRTX - Average Forecast Price
- market capitalization data:
Market Value BRTX|BRTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share BioRestorative Therapies|BRTX - Company Net Assets|Market Capitalization to Book Value Ratio biorestorative.com|BRTX - Company Assets
- debt and liquidity data:
Debt to Equity BioRestorative Therapies|BRTX - Long-Term Debt to Equity|Short-Term Debt to Equity BioRestorative Therapies, Inc.|BRTX - Company Debts|Debt to Book Capitalization Ratio BRTX|BRTX - Long-Term Debt Volume|Company Short-Term Debts BioRestorative Therapies
Summary company analytics:BioRestorative
Original product of BioRestorative Therapies, Inc.

This ratio determines the proportion of debt within the company's overall equity structure. Investors assess credit risk by comparing debt growth rates with net asset dynamics. By analyzing the debt-to-capitalization financial stability metric, one can identify hidden solvency trends. For BioRestorative Therapies (BRTX), this is critical when financing costly ESG initiatives. Effective liability management ensures the ethical development of stem cell products and the environmental safety of laboratories.

Competitors of BioRestorative Therapies

MESO: Debts to Book Capitalization|lineagecell.com - Debts to Book Value|SRZN: Debt to Book Capitalization Ratio|CCEL - Debt to Book Value|FBLG (fibrobiologics.com) - Debts to Book Capitalization|Longeveron Corporation (LGVN) - Debt to Book Value|Debts to Book Capitalization CELZ (Creative Medical Technology Holdings, Inc.)